AdvisorShares Psychedelics ETF (PSIL) Holdings
PSIL holdings summary
as of Oct 25, 2026- Holdings
- 25 positions listed
- Top 10 weight
- 65.1% of net assets
- Effective holdings
- 15 equal-weight equivalent
- Largest holding
- DFTX 11.52% Definium Therapeutics, Inc.
- Annual turnover
- 75.2% of the portfolio traded
All PSIL holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | DFTX | Definium Therapeutics, Inc. | Healthcare | 11.52% | $5.2M | $4.31B | — |
| 2 | CMPS | COMPASS Pathways plc | Healthcare | 10.68% | $4.8M | $1.49B | — |
| 3 | HELP | Helus Pharma Inc. | Healthcare | 8.36% | $3.8M | — | — |
| 4 | ABBV | AbbVie Inc. | Healthcare | 5.51% | $2.5M | $504.37B | 80.6 |
| 5 | LLY | Eli Lilly and Company | Healthcare | 5.46% | $2.5M | $1.12T | 42.2 |
| 6 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 5.24% | $2.4M | $13.79B | 19.9 |
| 7 | SPTX | Seaport Therapeutics, Inc. | Healthcare | 4.76% | $2.1M | $954.4M | — |
| 8 | JNJ | Johnson & Johnson | Healthcare | 4.61% | $2.1M | $615.87B | 38.8 |
| 9 | DRUG | Bright Minds Biosciences Inc. | Healthcare | 4.54% | $2.1M | $506.0M | — |
| 10 | RLMD | Relmada Therapeutics, Inc. | Healthcare | 4.44% | $2.0M | $330.7M | — |
| 11 | STIM | Neuronetics, Inc. | Healthcare | 3.99% | $1.8M | $143.6M | — |
| 12 | ANRO | Alto Neuroscience, Inc. | Healthcare | 3.80% | $1.7M | $861.0M | — |
| 13 | GHRS | GH Research PLC | Healthcare | 3.63% | $1.6M | $1.25B | — |
| 14 | SUPN | Supernus Pharmaceuticals, Inc. | Healthcare | 3.34% | $1.5M | $2.21B | — |
| 15 | NRXP | NRx Pharmaceuticals, Inc. | Healthcare | 3.26% | $1.5M | $112.6M | — |
| 16 | PBM | Psyence Biomedical Ltd. Common Shares | Healthcare | 2.32% | $1.0M | $16.5M | — |
| 17 | NEUP | Neuphoria Therapeutics Inc | Healthcare | 2.24% | $1.0M | $17.9M | — |
| 18 | OPTH | Optimi Health Corp. Common Shares | Healthcare | 1.85% | $837,043.95 | $19.4M | — |
| 19 | INDV | Indivior PLC | Healthcare | 1.17% | $529,144.42 | $3.83B | 11.6 |
| 20 | IXHL | Incannex Healthcare Limited | Healthcare | 0.95% | $428,167.84 | $35.4M | — |
| 21 | IGC | India Globalization Capital, Inc. | Healthcare | 0.50% | $225,175.53 | $25.4M | — |
| 22 | NUMI | Numinus Wellness Inc | Healthcare | 0.43% | $192,646.16 | — | — |
| 23 | SILO | Silo Pharma, Inc. | Healthcare | 0.26% | $118,641.84 | $2.4M | — |
| 24 | VTGN | VistaGen Therapeutics, Inc. | Healthcare | 0.16% | $72,287.49 | $8.9M | — |
Weights as a percentage of net assets. Value held = weight × net assets ($45.2M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
PSIL sector breakdown
Sum of the weights of the holdings in each sector.
PSIL top industries
PSIL overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF | 3.1% | 3 of 502 | 0.09% |
| DIA | SPDR Dow Jones Industrial Average ETF | 3.0% | 1 of 30 | 0.16% |
| VTI | Vanguard Total Stock Market ETF | 2.9% | 11 of 2,941 | 0.03% |
| IWM | iShares Russell 2000 ETF | 0.4% | 7 of 1,962 | 0.19% |
| VXUS | Vanguard Total International Stock ETF | 0.0% | 1 of 8,035 | 0.05% |
| QQQ | Invesco QQQ ETF | 0.0% | 0 of 101 | 0.17% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the PSIL portfolio
AdvisorShares Psychedelics ETF holds 25 positions. The ten largest make up 65.1% of the fund, so it behaves like a portfolio of about 15 equally weighted stocks. The biggest positions are Definium Therapeutics, Inc. (11.52%), COMPASS Pathways plc (10.68%), Helus Pharma Inc. (8.36%), AbbVie Inc. (5.51%), Eli Lilly and Company (5.46%).
By sector, Healthcare is 93.0%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: PSIL chart, PSIL performance, PSIL dividends, PSIL overview.
PSIL holdings FAQ
How many holdings does PSIL have?
PSIL holds 25 positions as of October 25, 2026.
What are the top 10 holdings of PSIL?
The ten largest holdings are Definium Therapeutics, Inc. (11.52%), COMPASS Pathways plc (10.68%), Helus Pharma Inc. (8.36%), AbbVie Inc. (5.51%), Eli Lilly and Company (5.46%), Neurocrine Biosciences, Inc. (5.24%), Seaport Therapeutics, Inc. (4.76%), Johnson & Johnson (4.61%), Bright Minds Biosciences Inc. (4.54%), Relmada Therapeutics, Inc. (4.44%). Together they are 65.1% of the fund.
What percentage of PSIL is Definium Therapeutics, Inc.?
Definium Therapeutics, Inc. is the largest holding at 11.52% of net assets, about $5.2M of the fund's $45.2M.
How concentrated is PSIL?
The top 10 holdings are 65.1% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) PSIL behaves like a portfolio of about 15 equally weighted stocks.